Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements

ConclusionMYC + DLBCL patients demonstrate aberrant PET response patterns compared to MYC- patients with more frequent progression during treatment after I-PET negative assessment and new lesions at sites that were not initially involved.Trial registration number and date of registrationHOVON-84: EudraCT: 2006 –005,174-42, retrospectively registered 01–08-2008. HOVON-130: EudraCT: 2014–002,654-39, registered 26–01-2015
Source: European Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research